Journal Article Summary
The article investigates the effectiveness of using an alcohol-based nasal antiseptic for universal nasal decolonization in reducing the risk of infections, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA). This topic is important because MRSA infections can lead to serious complications, especially in hospital settings, and traditional methods like mupirocin have led to resistance issues. The study aims to determine if this new approach can not only lower infection rates but also reduce healthcare costs associated with MRSA management.
The research was conducted over a 12-month period, where all inpatients and surgical patients received twice-daily applications of the alcohol-based nasal antiseptic. The study compared infection rates and costs before and after implementing this method. The findings showed a significant decrease in MRSA bacteremia and surgical site infections (SSI), with MRSA bacteremia dropping from 3 to 0 cases per 1,000 patient-days and SSI rates also declining. Additionally, the approach resulted in substantial cost savings, amounting to over $104,000 due to reduced need for personal protective equipment and nasal screening tests.
Despite the promising results, the study has limitations, including its observational design and the potential for other factors to influence infection rates. Patients should be aware that while this method shows promise, it may not be suitable for everyone, and individual circumstances can vary. It is essential for readers to discuss any concerns or questions about nasal decolonization and infection prevention with their healthcare providers to ensure safe and effective care tailored to their needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Arden Scott. 567. Does Universal Nasal Decolonization with an Alcohol-Based Nasal Antiseptic Reduce Infection Risk and Cost?. Open Forum Infectious Diseases 2019. DOI: 10.1093/ofid/ofz360.636. PMCID: PMC6811043.
Featured Pill Pals Product
Mupirocin Ointment 2% --- Generic for Bactroban --- TEVA Pharma
Mupirocin Ointment 2% — Generic for Bactroban — TEVA Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
